Latest Stories
Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how pharmaceuticals stocks fared in Q4, starting with Elanco (NYSE:ELAN).
Getty Images (NYSE:GETY) Posts Better-Than-Expected Sales In Q4 But Full-Year Sales Guidance Misses Expectations
Visual content marketplace Getty Images (NYSE:GETY) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 9.5% year on year to $247.3 million. On the other hand, the company’s full-year revenue guidance of $936.5 million at the midpoint came in 2.3% below analysts’ estimates. Its GAAP profit of $0.06 per share was $0.02 above analysts’ consensus estimates.
Why SAIC (SAIC) Stock Is Up Today
Shares of government IT services provider Science Applications International Corporation (NASDAQ:SAIC) jumped 11.7% in the morning session after the company reported impressive fourth quarter 2024 (fiscal 2025) results, which blew past analysts' sales and earnings estimates.